Pharmafile Logo
Pharmafocus logo
Advanced Search
boehringer_biberach_germany_copy

Researchers and pharma companies partner to investigate new schizophrenia treatment

January 21, 2021
Biogen, Boehringer Ingelheim

The University of Oxford, the Earlham Institute, and global pharmaceutical companies Biogen and Boehringer Ingelheim are partnering to investigate a …

News

Thousands of Israelis test positive for COVID-19 after receiving Pfizer jab

January 21, 2021
COVID-19, Pfizer, israel

Thousands of people in Israel have tested positive for coronavirus after receiving the Pfizer vaccine, including some who had been …

News
gilead-sciences

NICE recommends rheumatoid arthritis drug Jyseleca for NHS use

January 21, 2021
Gilead, NICE

NICE has issued a final appraisal determination (FAD) recommending the use of Jyseleca (filgotinib) on the NHS in England for …

News
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …

Appointment
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 20, 2021
Research and Development

The past week has seen promising developments in the race to find treatments for COVID-19; Jubilant and The Wistar Institute …

News
stem_cell

Scientists in Scotland make breakthrough MND discovery

January 20, 2021
Research and Development motor neurone disease

Researchers in Scotland have made a discovery that could reverse the damage caused by motor neurone disease (MND). University of …

News

NICE approves lipid disorder drug Myalepta for NHS use

January 20, 2021
Research and Development Amryt Pharma, NICE

NICE has approved Amryt’s rare lipid disorder drug Myalepta (metreleptin), currently the only leptin replacement therapy available, for use within …

News
astrazeneca_sign_sky

EU approves breast cancer drug Enhertu

January 20, 2021
Research and Development AstraZeneca, Daiichi Sankyo

The EU has granted AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) conditional approval as a monotherapy for the treatment of …

News

Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says

January 20, 2021
Research and Development COVID-19, Pfizer

The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …

News
img_4190-e1376666350337-web

MHRA grants Promising Innovative Medicine Designation to Sanofi’s RSV drug

January 19, 2021
Manufacturing and Production MHRA, Sanofi

The MHRA has granted a Promising Innovative Medicine (PIM) Designation to Sanofi’s nirsevimab, which is being investigated a passive immunisation …

News

NICE recommends cutting-edge lymphoma treatment for NHS use

January 19, 2021
Manufacturing and Production Cancer, NICE

NHS clinicians in England will be able to consider a cutting-edge cancer treatment for some patients with a form of …

News
covaxin

Bharat Biotech advises certain groups against taking its COVID-19 vaccine

January 19, 2021
Manufacturing and Production Bharat Biotech, COVID-19

India’s vaccine developer Bharat Biotech has advised a number of groups to avoid taking its homegrown COVID-19 vaccine, Covaxin. According …

News

Novartis’ Cosentyx available on NHS in Scotland

January 19, 2021
Manufacturing and Production Novartis

Novartis has announced that Cosentyx (secukinumab) 150mg is available in Scotland on the NHS, licensed for adults with active non-radiographic …

News

ConserV and Lawrence Livermore National Laboratory to collaborate on coronavirus vaccine

January 19, 2021
Manufacturing and Production COVID-19, ConserV Bioscience

ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and Lawrence …

News
jubilant

Jubilant and The Wistar Insitute collaborate on potential COVID-19 treatment

January 18, 2021
Sales and Marketing Jubilant Therapeutics

Jubilant Therapeutics, a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, has …

News
senior-woman-suffering-from-knee-pain-home_61573-2004

Theramex launches osteoporosis drug Livogiva in Europe

January 18, 2021
Sales and Marketing Theramex, osteoporosis

Theramex, a London-headquartered pharmaceutical company dedicated to women’s health, has launched osteoporosis medicine Livogiva to patients in Europe for the …

News
viiv

ViiV and Chelsea & Westminster Hospital launch digital service for HIV patients

January 18, 2021
Sales and Marketing HIV, ViiV Healthcare

Global specialist HIV company ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust have launched a new service, Klick, …

News
pentagon-headquarters-us-department-of-defense-virginia

US Department of Defense selects Faron for $6.1m COVID-19 research funding

January 18, 2021
Sales and Marketing Faron Pharmaceuticals, US

The US Department of Defense (DoD) has selected Faron Pharmaceuticals’ HIBISCUS study to receive $6.1 million of funding from the …

News
janssen_latest_logo_on_sign

FDA approves Janssen’s AL amyloidosis drug

January 18, 2021
Sales and Marketing FDA, Janssen

The FDA has approved Janssen’s DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 15, 2021
Medical Communications COVID-19

Pharmafile.com’s most popular stories this week include the use of two new, potentially life-saving treatments for on COVID-19 patients, and …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026